Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen s Q4 Revenues Grow 24 Percent as Profit Jumps 63 Percent

NEW YORK, Feb. 28 (GenomeWeb News) - Invitrogen today reported double-digit growth in revenues and profits for the fourth quarter of 2005.


Total receipts for the three months ended Dec. 31, 2005, rose 24 percent to $325.3 million from $262.2 million in the prior-year period. Acquisitions generated 17 percent of the quarterly revenue growth, Invitrogen said, while currency exchange rates had a negative impact of 4 percent on quarterly revenues, resulting in net organic growth of 11 percent for the period.


Invitrogen reported quarterly organic revenue growth of 12 percent in its BioDiscovery business unit and 8 percent organic growth in its BioProduction business.


Invitrogen's net income for the fourth quarter grew 63 percent to $49.6 million versus $30.5 million for the same quarter in 2004.  


R&D spending rose 36 percent to $27.4 million in the fourth quarter of 2005 from $20 million in the year-ago period.


Invitrogen had $751 million in cash and investments as of Dec. 31, 2005.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.